Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Typhoid treatment was empirically started in a Japanese patient with undifferentiated fever in Nepal since Japanese tourists, unlike most Americans and Europeans to South Asia, are unable to obtain typhoid vaccination in Japan even for travel to this area of high endemicity. Subsequently, his blood culture grew out Salmonella typhi.

Original publication

DOI

10.1111/j.1708-8305.2010.00394.x

Type

Journal article

Journal

J Travel Med

Publication Date

05/2010

Volume

17

Pages

199 - 200

Keywords

Abdominal Pain, Adult, Anti-Infective Agents, Asians, Ciprofloxacin, Humans, Japan, Male, Nepal, Salmonella typhi, Travel, Typhoid Fever, Typhoid-Paratyphoid Vaccines